Siemens Government Technologies has been awarded a contract over $1.78M by the FDA to implement an Advanced Digital Design and Manufacturing line as part of the FDA’s Advanced Manufacturing and Supply Chain programs. This partnership aims to enhance product development, increase manufacturing capacity, and improve product quality in the Lifesciences sector. The initiative will leverage Siemens Digital Industries’ software, facilitating the evaluation and adoption of advanced manufacturing processes, ultimately reducing supply chain shortages and accelerating responses to public health challenges.
Siemens Healthineers has received De Novo marketing authorization for the Enhanced Liver Fibrosis (ELF) Test, an innovative blood test for patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH). This test aids in assessing the risk of progression to cirrhosis and liver-related complications. The ELF Test, which was previously granted Breakthrough Device Designation in November 2018, offers a noninvasive, convenient, and reproducible solution for diagnosing advanced liver conditions.
Siemens is committing to expand its U.S. manufacturing operations to support electric vehicle (EV) infrastructure, planning to produce over 1 million EV chargers in the next four years. This investment aligns with the $1 trillion bipartisan infrastructure bill and aims to create 100 jobs. Siemens will unveil a new facility for AC charger manufacturing in early 2022, complementing its existing operations in North Carolina. The company emphasizes enhancing U.S. infrastructure and job growth in electrification.
Siemens Healthineers has launched WeScan, a remote MRI examination service utilizing TeamViewer's technology to address radiology staff shortages. This service connects healthcare providers with skilled remote technologists who operate MRI scanners using Siemens' syngo Virtual Cockpit. The partnership highlights secure data transmission and high-performance access, crucial for healthcare. WeScan aims to enhance device utilization and patient access while responding to the increasing demand for remote healthcare solutions.
Varian announced CEO Dow Wilson's retirement after 16 years, coinciding with its merger with Siemens Healthineers. Chris Toth, current President and COO, will succeed him as the CEO of Varian's segment within Siemens. Wilson will assist as a special advisor post-transition. Under Wilson's leadership since 2012, Varian achieved double-digit growth and expanded its market presence in cancer care, creating 4,000 jobs. The merger is anticipated to complete in H1 2021, furthering Varian's vision for innovative cancer treatment.